Gilead Sciences (GILD): Bright Spots Among The Misses - Stifel

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. PLTR
6. JNJ
7. HUM
8. CSCO
9. KTOS
10. NVDA

Go back to Gilead Sciences (GILD): Bright Spots Among The Misses - Stifel

Bullish Options Activity in Gilead Sciences (GILD) Post Earnings Announcement -Susquehanna

May 3, 2017 2:46 PM EDT

Susquehanna options strategists Alison Edwards notes bullish options activity in Gilead Sciences (NASDAQ: GILD), following the company's earnings announcement, as an opening investor bought ~10,000 Dec 70 Calls for $3.30 creating ~400,000 shares to buy.

... More

Gilead Sciences (GILD) PT Raised to $76 at BMO Capital Following 1Q

May 3, 2017 9:17 AM EDT

BMO Capital raised its price target on Gilead Sciences (NASDAQ: GILD) to $76.00 (from $75.00) while maintaining a Market Perform rating. GILD reported 1Q revenues of $6.5bn, below the Street's estimates of $6.62bn, as continued strength from HIV could not off-set further deterioration in HCV.

GILD... More